IMVT - Company ID 0001764013
As of 2026-11-06, Immunovant, Inc. (IMVT) has a market capitalization of $6.17 B, making it the #1236 most valuable US-listed company.
| Date | Market cap |
|---|---|
| 2026-11-06 | $6.17 B |
| 2026-11-05 | $5.85 B |
| 2026-11-04 | $6.14 B |
| 2026-11-03 | $5.96 B |
| 2026-11-02 | $5.86 B |
| 2026-11-01 | $5.99 B |
| 2026-10-31 | $5.99 B |
| 2026-10-30 | $5.99 B |
| 2026-10-29 | $6.09 B |
| 2026-10-28 | $6.04 B |
| 2026-10-27 | $5.93 B |
| 2026-10-26 | $5.80 B |
As of 2026-11-06, Immunovant, Inc. (IMVT) has a market capitalization of $6.17 B, making it the #1236 most valuable US-listed company.
Immunovant, Inc. is the #1236 largest US-listed company by market capitalization.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| 2026-10-25 | $5.83 B |
| 2026-10-24 | $5.83 B |
| 2026-10-23 | $5.85 B |
| 2026-10-22 | $5.97 B |
| 2026-10-21 | $5.79 B |
| 2026-10-20 | $5.92 B |
| 2026-10-19 | $5.67 B |
| 2026-10-18 | $5.49 B |
| 2026-10-17 | $5.49 B |
| 2026-10-16 | $5.49 B |
| 2026-10-15 | $5.65 B |
| 2026-10-14 | $5.73 B |
| 2026-10-13 | $5.94 B |
| 2026-10-12 | $6.05 B |
| 2026-10-11 | $6.26 B |
| 2026-10-10 | $6.26 B |
| 2026-10-09 | $6.26 B |
| 2026-10-08 | $6.21 B |
Readings accumulate daily as market data refreshes, combining SEC-reported share counts with live prices.